153 related articles for article (PubMed ID: 23713804)
1. Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells.
Berglin L; Björkström NK; Bergquist A
Scand J Gastroenterol; 2013 Jun; 48(6):719-28. PubMed ID: 23713804
[TBL] [Abstract][Full Text] [Related]
2. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Jendrek ST; Gotthardt D; Nitzsche T; Widmann L; Korf T; Michaels MA; Weiss KH; Liaskou E; Vesterhus M; Karlsen TH; Mindorf S; Schemmer P; Bär F; Teegen B; Schröder T; Ehlers M; Hammers CM; Komorowski L; Lehnert H; Fellermann K; Derer S; Hov JR; Sina C
Gut; 2017 Jan; 66(1):137-144. PubMed ID: 27406039
[TBL] [Abstract][Full Text] [Related]
3. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.
Xu B; Broome U; Ericzon BG; Sumitran-Holgersson S
Gut; 2002 Jul; 51(1):120-7. PubMed ID: 12077104
[TBL] [Abstract][Full Text] [Related]
4. TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics.
Matsushita H; Miyake Y; Takaki A; Yasunaka T; Koike K; Ikeda F; Shiraha H; Nouso K; Yamamoto K
J Gastroenterol Hepatol; 2015 Mar; 30(3):600-8. PubMed ID: 25160604
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
Lenzen H; Weismüller TJ; Negm AA; Wlecke J; Loges S; Strassburg CP; Manns MP; Lankisch TO
Scand J Gastroenterol; 2013 Oct; 48(10):1205-12. PubMed ID: 23957616
[TBL] [Abstract][Full Text] [Related]
6. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.
Karrar A; Broomé U; Södergren T; Jaksch M; Bergquist A; Björnstedt M; Sumitran-Holgersson S
Gastroenterology; 2007 Apr; 132(4):1504-14. PubMed ID: 17408653
[TBL] [Abstract][Full Text] [Related]
7. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.
Tornai T; Palyu E; Vitalis Z; Tornai I; Tornai D; Antal-Szalmas P; Norman GL; Shums Z; Veres G; Dezsofi A; Par G; Par A; Orosz P; Szalay F; Lakatos PL; Papp M
World J Gastroenterol; 2017 Aug; 23(29):5412-5421. PubMed ID: 28839442
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
Ardesjö B; Hansson CM; Bruder CE; Rorsman F; Betterle C; Dumanski JP; Kämpe O; Ekwall O
J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955
[TBL] [Abstract][Full Text] [Related]
9. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis.
Schwarze C; Terjung B; Lilienweiss P; Beuers U; Herzog V; Sauerbruch T; Spengler U
Clin Exp Immunol; 2003 Aug; 133(2):283-9. PubMed ID: 12869036
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.
Novotný I; Dítě P; Trna J; Lata J; Husová L; Geryk E
Dig Dis; 2012; 30(2):216-9. PubMed ID: 22722442
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium.
Mandal A; Dasgupta A; Jeffers L; Squillante L; Hyder S; Reddy R; Schiff E; Das KM
Gastroenterology; 1994 Jan; 106(1):185-92. PubMed ID: 7506217
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
13. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
14. Sulphite oxidase (SO) - a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis.
Preuß BE; Berg CP; Werner C; Plankenhorn S; Malek NP; Klein R
BMC Gastroenterol; 2018 May; 18(1):58. PubMed ID: 29720090
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis.
Orth T; Kellner R; Diekmann O; Faust J; Meyer zum Büschenfelde KH; Mayet WJ
Clin Exp Immunol; 1998 Jun; 112(3):507-15. PubMed ID: 9649223
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in primary sclerosing cholangitis.
Hov JR; Boberg KM; Karlsen TH
World J Gastroenterol; 2008 Jun; 14(24):3781-91. PubMed ID: 18609700
[TBL] [Abstract][Full Text] [Related]
19. Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype.
Sowa M; Kolenda R; Baumgart DC; Pratschke J; Papp M; Tornai T; Suchanski J; Bogdanos DP; Mytilinaiou MG; Hammermann J; Laass MW; Conrad K; Schramm C; Franke A; Roggenbuck D; Schierack P
Front Immunol; 2018; 9():1959. PubMed ID: 30233574
[No Abstract] [Full Text] [Related]
20. Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.
Tornai T; Tornai D; Sipeki N; Tornai I; Alsulaimani R; Fechner K; Roggenbuck D; Norman GL; Veres G; Par G; Par A; Szalay F; Lakatos PL; Antal-Szalmas P; Papp M
Sci Rep; 2018 Jan; 8(1):399. PubMed ID: 29321484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]